A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog in Patients With T2DM
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 09 Apr 2018 Status changed from active, no longer recruiting to completed.
- 05 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 04 Dec 2017 Planned End Date changed from 1 May 2018 to 1 Mar 2018.